InvestorsHub Logo
Followers 187
Posts 38000
Boards Moderated 4
Alias Born 09/24/2000

Re: justus1 post# 16

Wednesday, 05/15/2024 6:00:06 AM

Wednesday, May 15, 2024 6:00:06 AM

Post# of 382
Well I'm thinking this news should give it the boost for 10-20% gain. Hopefully for us it does.


Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved

- On Track to Regain Compliance with All Nasdaq Listing Requirements

- No Variable Priced Securities are Outstanding
Bullish
Bullish

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.